XRF Scientific Ltd (ASX: XRF) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
XRF Scientific Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$287.41 million
P/E Ratio
28.65
Dividend Yield
2.12%
Shares Outstanding
142.99 million
Earnings per share
0.074
Dividend per share
0.05
Year To Date Return
2.91%
Earnings Yield
3.49%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
XRF Scientific Ltd (ASX: XRF)
Latest News
Small Cap Shares
Hidden gems: Experts name 3 ASX small-cap shares to buy now
Small Cap Shares
'Bright outlook': 2 ASX shares ready for a massive 2024 you've not thought about
Investing Strategies
'Supercharge recurring revenue': 3 ASX shares to buy before everyone else wakes up
Investing Strategies
'Surprise to upside': 2 ASX shares to buy now for future growth
Share Market News
Top fund manager has 'never seen' ASX share price moves like we are witnessing
Broker Notes
2 totally obscure ASX shares in the buy zone right now: experts
Ask a Fund Manager
3 hot ASX shares to buy right now: advisor
Broker Notes
3 intriguing ASX shares to buy before reporting season
Share Gainers
XRF Scientific (ASX:XRF) share price soars 14% on revenue growth
Share Market News
4 high yield ASX dividend shares to buy right now
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 12 Sep 2024 | $0.0390 | 100.00% | Final | 27 Sep 2024 |
| 28 Sep 2023 | $0.0330 | 100.00% | Final | 13 Oct 2023 |
| 29 Sep 2022 | $0.0250 | 100.00% | Final | 14 Oct 2022 |
| 30 Sep 2021 | $0.0200 | 100.00% | Final | 15 Oct 2021 |
| 01 Oct 2020 | $0.0140 | 100.00% | Final | 16 Oct 2020 |
| 03 Oct 2019 | $0.0100 | 100.00% | Final | 18 Oct 2019 |
| 04 Oct 2018 | $0.0030 | 100.00% | Final | 19 Oct 2018 |
| 14 Sep 2017 | $0.0000 | 100.00% | Final | 29 Sep 2017 |
| 15 Sep 2016 | $0.0030 | 100.00% | Final | 30 Sep 2016 |
| 17 Feb 2016 | $0.0020 | 100.00% | Interim | 04 Mar 2016 |
| 10 Sep 2014 | $0.0110 | 100.00% | Final | 26 Sep 2014 |
XRF ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About XRF Scientific Ltd
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
XRF Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 05 Feb 2026 | $2.01 | $-0.06 | -2.90% | 146,440 | $2.09 | $2.09 | $2.01 |
| 04 Feb 2026 | $2.07 | $-0.05 | -2.36% | 89,829 | $2.11 | $2.15 | $2.06 |
| 03 Feb 2026 | $2.12 | $0.01 | 0.47% | 56,766 | $2.07 | $2.14 | $2.07 |
| 02 Feb 2026 | $2.11 | $-0.06 | -2.76% | 164,434 | $2.17 | $2.17 | $2.09 |
| 30 Jan 2026 | $2.17 | $-0.03 | -1.36% | 59,201 | $2.25 | $2.25 | $2.15 |
| 29 Jan 2026 | $2.20 | $-0.03 | -1.35% | 64,498 | $2.19 | $2.26 | $2.17 |
| 28 Jan 2026 | $2.23 | $-0.02 | -0.89% | 98,205 | $2.25 | $2.26 | $2.19 |
| 27 Jan 2026 | $2.25 | $0.13 | 6.13% | 489,604 | $2.14 | $2.25 | $2.13 |
| 23 Jan 2026 | $2.12 | $0.04 | 1.92% | 128,495 | $2.08 | $2.16 | $2.08 |
| 22 Jan 2026 | $2.08 | $-0.06 | -2.80% | 90,396 | $2.15 | $2.15 | $2.07 |
| 21 Jan 2026 | $2.14 | $0.13 | 6.47% | 111,615 | $2.05 | $2.14 | $2.00 |
| 20 Jan 2026 | $2.01 | $-0.08 | -3.83% | 146,906 | $2.07 | $2.08 | $2.01 |
| 19 Jan 2026 | $2.09 | $-0.06 | -2.79% | 106,291 | $2.14 | $2.14 | $2.07 |
| 16 Jan 2026 | $2.15 | $0.03 | 1.42% | 49,121 | $2.14 | $2.15 | $2.12 |
| 15 Jan 2026 | $2.12 | $-0.05 | -2.30% | 78,133 | $2.17 | $2.17 | $2.12 |
| 14 Jan 2026 | $2.17 | $0.04 | 1.88% | 50,635 | $2.16 | $2.18 | $2.15 |
| 13 Jan 2026 | $2.13 | $-0.02 | -0.93% | 188,396 | $2.17 | $2.18 | $2.13 |
| 12 Jan 2026 | $2.15 | $0.02 | 0.94% | 79,265 | $2.17 | $2.18 | $2.13 |
| 09 Jan 2026 | $2.13 | $-0.06 | -2.74% | 52,147 | $2.19 | $2.20 | $2.12 |
| 08 Jan 2026 | $2.19 | $0.06 | 2.82% | 116,530 | $2.10 | $2.19 | $2.10 |
| 07 Jan 2026 | $2.13 | $0.04 | 1.91% | 168,101 | $2.10 | $2.13 | $2.08 |
| 06 Jan 2026 | $2.09 | $0.04 | 1.95% | 40,244 | $2.05 | $2.10 | $2.05 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 03 Nov 2025 | Vance Stazzonelli | Issued | 146,725 | $318,393 |
Issue of securities. 547,375 Rights
|
| 23 Oct 2025 | Vance Stazzonelli | Buy | 5,912 | $12,355 |
On-market trade.
|
| 26 Sep 2025 | David Kiggins | Issued | 1,933 | $4,059 |
Dividend Reinvestment Plan (DRP).
|
| 26 Sep 2025 | Frederick Grimwade | Issued | 11,822 | $24,826 |
Dividend Reinvestment Plan (DRP).
|
| 08 Sep 2025 | David Brown | Sell | 1,000,000 | $2,127,305 |
On-market trade.
|
| 21 Aug 2025 | Vance Stazzonelli | Issued | 384,088 | $810,426 |
Conversion of securities. VWAP, estimated value
|
| 21 Aug 2025 | Vance Stazzonelli | Exercise | 384,088 | $810,426 |
Conversion of securities. 400,650 Rights, estimated value, VWAP
|
| 21 Aug 2025 | Vance Stazzonelli | Expiry | 18,415 | $41,617 |
As advised by the company. Lapsed, 7,84,738 Rights
|
| 26 May 2025 | Vance Stazzonelli | Buy | 3,336 | $5,421 |
On-market trade.
|
| 23 May 2025 | Vance Stazzonelli | Buy | 6,664 | $10,829 |
Off-market trade.
|
| 14 Mar 2025 | David Brown | Buy | 32,000 | $56,960 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David William Kiggins | Non-Executive Director | May 2012 |
Mr Kiggins is currently Chief Financial Officer at Sadleirs, David brings experience across listed and private companies. Previously held CFO roles at Stealth Global Holdings Ltd and Heliwest; Finance Director and Company Secretary at Global Construction Services Ltd; GM Business Development and Company Secretary at Automotive Holdings Group Ltd; audit and international business consulting roles at Arthur Andersen. He is chairman of the Governance Committee.
|
| Sir David Maxwell Brown | Non-Executive Director | Feb 2004 |
Mr Brown has experience in research and development and manufacturing of X-Ray Flux chemicals; formerly Chief Chemist for Swan Brewery Co. Ltd and Chairman of Scientific Industries Council of WA.
|
| Mr Frederick Sheppard Grimwade | Non-Executive DirectorNon-Executive Chairman | May 2012 |
Mr Grimwade has held general management positions at Colonial Agricultural Company, the Colonial Group, Western Mining Corporation and Goldman, Sachs & Co. Currently a Principal and Director of Fawkner Capital. Other current directorships: Non-Executive Director of Australian United Investment Company Ltd (since March 2014) and other private companies. Former directorships in last 3 years include Chairman/Director of CPT Global Ltd (October 2002 to November 2023); Non-Executive Director of Select Harvests Ltd (July 2010 to February 2023) and other private companies. He is member of the Governance Committee.
|
| Mr Vance Stazzonelli | Company SecretaryChief Executive OfficerManaging Director | Jun 2008 |
Mr Stazzonelli was appointed to Chief Operating Officer in January 2011 and then Chief Executive Officer in August 2012. On 22 February 2018, he was appointed as Managing Director.
|
| Mr Andrew Watson | Joint Company SecretaryChief Financial Officer | Aug 2013 |
-
|
| Andrew Watson | Joint Company SecretaryChief Financial Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 11,034,778 | 7.85% |
| Michael Karl Korber | 8,611,321 | 6.13% |
| Evelin Investments Pty Limited | 7,510,622 | 5.34% |
| Citicorp Nominees Pty Limited | 6,412,210 | 4.56% |
| D & Gd Brown Nominees Pty Ltd 1 | 5,758,072 | 4.10% |
| J P Morgan Nominees Australia Pty Limited | 4,790,026 | 3.41% |
| Pandora Super (Wa) Pty Ltd 2 | 3,466,128 | 2.47% |
| Chabar Pty Ltd | 3,080,136 | 2.19% |
| Great Western Capital Pty Ltd | 3,017,891 | 2.15% |
| Stephen William Prossor & Fiona Christian Prossor | 2,669,767 | 1.90% |
| G & E Properties Pty Ltd | 2,212,275 | 1.57% |
| Jeffrey David Brown & Penny Narelle Brown | 1,790,079 | 1.27% |
| Frederic Davidts | 1,672,561 | 1.19% |
| BNP Paribas Nominees Pty Ltd | 1,276,007 | 0.91% |
| Netwealth Investments Limited | 1,217,578 | 0.87% |
| BNP Paribas Noms Pty Ltd | 972,640 | 0.69% |
| BNP Paribas Nominees Pty Ltd i | 967,565 | 0.69% |
| Jasna Hay | 900,000 | 0.64% |
| Vance Albert Stazzonelli | 850,000 | 0.60% |
| Pebadore Pty Ltd | 800,000 | 0.57% |
